TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES AND THE SAFETY OF NATURALLY-DERIVED BIOLOGICALS

被引:2
作者
DIMARTINO, A [1 ]
机构
[1] NINCDS,CENT NERVOUS SYST STUDIES,BETHESDA,MD 20892
关键词
D O I
10.1006/biol.1993.1047
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Late in 1986, a new neurodegenerative disease, referred to as bovine spongiform encephalopathy (BSE), was recognized in domestic cattle in southern England. Since then, tens of thousands of cases have been confirmed throughout the U.K. and the disease has also appeared sporadically outside of the British Isles. BSE belongs to a group of rare, progressive and fatal disorders of the central nervous system of animals and man caused by anomalous infectious agents whose properties are not yet full understood. Consequently, fears were raised about the possibility that the disease might constitute a possible health risk for humans. Minimization of potential contamination has thus become an issue of growing interest. This short review summarizes the main aspects of the problem together with the procedures developed to sterilize preparation of biologicals even from sources containing potentially high levels of contamination. © 1993 Academic Press, Inc.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 73 条
[1]   DOES AGENT OF SCRAPIE REPLICATE WITHOUT NUCLEIC ACID [J].
ALPER, T ;
CRAMP, WA ;
HAIG, DA ;
CLARKE, MC .
NATURE, 1967, 214 (5090) :764-&
[2]  
[Anonymous], 1991, Biologicals, V19, P247
[3]  
BASLER K, 1986, CELL, V46, P416
[4]   PURIFIED SCRAPIE PRIONS RESIST INACTIVATION BY PROCEDURES THAT HYDROLYZE, MODIFY, OR SHEAR NUCLEIC-ACIDS [J].
BELLINGERKAWAHARA, C ;
DIENER, TO ;
MCKINLEY, MP ;
GROTH, DF ;
SMITH, DR ;
PRUSINER, SB .
VIROLOGY, 1987, 160 (01) :271-274
[5]   NEARLY UBIQUITOUS TISSUE DISTRIBUTION OF THE SCRAPIE AGENT PRECURSOR PROTEIN [J].
BENDHEIM, PE ;
BROWN, HR ;
RUDELLI, RD ;
SCALA, LJ ;
GOLLER, NL ;
WEN, GY ;
KASCSAK, RJ ;
CASHMAN, NR ;
BOLTON, DC .
NEUROLOGY, 1992, 42 (01) :149-156
[6]   SCRAPIE - CONCEPT OF A VIRUS-INDUCED AMYLOIDOSIS OF THE BRAIN [J].
BRAIG, HR ;
DIRINGER, H .
EMBO JOURNAL, 1985, 4 (09) :2309-2312
[7]   POTENTIAL EPIDEMIC OF CREUTZFELDT-JAKOB DISEASE FROM HUMAN GROWTH-HORMONE THERAPY [J].
BROWN, P ;
GAJDUSEK, DC ;
GIBBS, CJ ;
ASHER, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :728-731
[8]   THE EPIDEMIOLOGY OF CREUTZFELDT-JAKOB DISEASE - CONCLUSION OF A 15-YEAR INVESTIGATION IN FRANCE AND REVIEW OF THE WORLD LITERATURE [J].
BROWN, P ;
CATHALA, F ;
RAUBERTAS, RF ;
GAJDUSEK, DC ;
CASTAIGNE, P .
NEUROLOGY, 1987, 37 (06) :895-904
[9]   DIAGNOSIS OF CREUTZFELDT-JAKOB DISEASE BY WESTERN-BLOT IDENTIFICATION OF MARKER PROTEIN IN HUMAN-BRAIN TISSUE [J].
BROWN, P ;
COKERVANN, M ;
POMEROY, K ;
FRANKO, M ;
ASHER, DM ;
GIBBS, CJ ;
GAJDUSEK, DC .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (09) :547-551
[10]   THE NEW BIOLOGY OF SPONGIFORM ENCEPHALOPATHY - INFECTIOUS AMYLOIDOSES WITH A GENETIC TWIST [J].
BROWN, P ;
GOLDFARB, LG ;
GAJDUSEK, DC .
LANCET, 1991, 337 (8748) :1019-1022